CN Stock MarketDetailed Quotes

600422 KPC Pharmaceuticals, Inc.

Watchlist
  • 22.72
  • -0.15-0.66%
Market Closed Apr 30 15:00 CST
17.20BMarket Cap39.79P/E (TTM)

KPC Pharmaceuticals, Inc. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

KPC Pharmaceuticals, Inc. Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

1.85B

-3.01%
EPS(YoY)

0.16

-5.88%
Analyst Rating

Strong Buy

May 1, 2024

KPC Pharmaceuticals, Inc. Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 10.014B--
--2024/FY-- / 8.579B--
Mar 22, 20242023/FY7.703B / 8.380B--
Mar 23, 20232022/FY8.282B / 8.537B--
Mar 19, 20222021/FY8.254B / 9.065B--
Mar 16, 20212020/FY7.717B / 8.990B--
Mar 31, 20202019/FY8.120B / ----
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 10.014B--
--2024/FY-- / 8.579B--
Mar 22, 20242023/FY7.703B / 8.380B--
Mar 23, 20232022/FY8.282B / 8.537B--
Mar 19, 20222021/FY8.254B / 9.065B--
Mar 16, 20212020/FY7.717B / 8.990B--
Mar 31, 20202019/FY8.120B / ----
--------
--------
--------

Unlock Free Earnings Estimates

KPC Pharmaceuticals, Inc. Earnings Reports

  • KPC Group Report for the First Quarter of 2024

    Apr 20 00:00

  • Summary of KPC's 2023 Annual Report

    Mar 22 00:00

  • KPC 2023 Annual Report

    Mar 22 00:00

  • Kunyao Group\'s report for the third quarter of 2023

    Oct 28, 2023 00:00

    • Read more

    Analysis

    Analyst Rating

    Updated: May 1, 2024

    Strong Buy

    • Strong Buy

      76.92%

    • Buy

      23.08%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg